Mycophenolate therapy of SLE membranous nephropathy

Slides:

Advertisements

Similar presentations

Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup

Advertisements

Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares D.J. Birmingham,

Volume 68, Issue 4, Pages (October 2005)

Biomarkers of lupus nephritis determined by serial urine proteomics

Plasma sodium and hypertension

Propofol-related green urine

Volume 94, Issue 4, Pages (October 2018)

Volume 81, Issue 4, Pages (February 2012)

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Demetrios J. Kutsogiannis, R.T.Noel.

Membranous nephropathy: When and how to treat

Mycophenolate mofetil treatment for primary glomerular diseases

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Volume 80, Issue 10, Pages (November 2011)

Progression of renal failure and hypertensive nephrosclerosis

Volume 80, Issue 2, Pages (July 2011)

Volume 58, Issue 1, Pages (July 2000)

Volume 71, Issue 8, Pages (April 2007)

Volume 70, Pages S21-S25 (December 2006)

Volume 68, Issue 2, Pages (August 2005)

Volume 68, Issue 4, Pages (October 2005)

Volume 65, Issue 1, Pages (January 2004)

Volume 72, Issue 7, Pages (October 2007)

Methotrexate in the urine

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

Renal risk scores: Progress and prospects

Nephrology Crosswords: Hemodialysis

Volume 70, Issue 12, Pages (December 2006)

U-shaped effect of eGFR and mortality

Volume 70, Issue 12, Pages (December 2006)

David J. Leehey, MD, Tony Casini, MS, Donald Massey, DO

Biomarkers of lupus nephritis determined by serial urine proteomics

The third World Kidney Day: Looking back and thinking forward

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 74, Issue 8, Pages (October 2008)

Methods for guideline development

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Volume 1, Issue 2, Pages (March 2019)

Volume 78, Issue 5, Pages (September 2010)

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

Volume 60, Issue 1, Pages (July 2001)

Volume 66, Issue 3, Pages (September 2004)

Volume 76, Issue 12, Pages (December 2009)

Proteinuria in obstructive sleep apnea

Volume 82, Issue 9, Pages (November 2012)

The course of the remnant kidney model in mice

Organ transplantation goes to the movies

Atherosclerotic nephropathy

Volume 64, Issue 4, Pages (October 2003)

Is complement a target for therapy in renal disease?

Urinalysis in Western culture: A brief history

Volume 70, Issue 3, Pages (August 2006)

Volume 70, Issue 5, Pages (September 2006)

Membranous nephropathy: recent travels and new roads ahead

Volume 72, Issue 11, Pages (December 2007)

Adiponectin: good, bad, or just plain ugly?

The international realities of live donor kidney transplantation

The International Pediatric Peritonitis Registry: Starting to walk

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

Prediction in idiopathic membranous nephropathy

Volume 72, Issue 12, (December 2007)

Volume 54, Pages S112-S119 (December 1998)

Volume 56, Issue 6, Pages (December 1999)

Volume 57, Pages S44-S48 (April 2000)

Volume 66, Issue 5, Pages (November 2004)

Volume 77, Issue 2, Pages (January 2010)

Presentation transcript:

Mycophenolate therapy of SLE membranous nephropathy D.A.N.N. Spetie, Yuxiao Tang, Brad H. Rovin, Tibor Nadasdy, Gyongyi Nadasdy, Todd E. Pesavento, L.E.E.A. Hebert, M.D. Kidney International Volume 66, Issue 6, Pages 2411-2415 (December 2004) DOI: 10.1111/j.1523-1755.2004.66030.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Sequential changes in urine protein/creatinine ratio in the study cohort during study follow-up. Kidney International 2004 66, 2411-2415DOI: (10.1111/j.1523-1755.2004.66030.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Kaplan-Meier estimates of the probability of a complete remission or the composite of a complete or partial remission during follow-up in the study. Kidney International 2004 66, 2411-2415DOI: (10.1111/j.1523-1755.2004.66030.x) Copyright © 2004 International Society of Nephrology Terms and Conditions